Home / Publications / Pain Research Forum / Papers of the Week / Maintenance of response and predictive factors of one-year GalcanezumAb treatment in Real Life migraine patients in ITaly: the multicenter prospective cohort GARLIT study.
Maintenance of response and predictive factors of one-year GalcanezumAb treatment in Real Life migraine patients in ITaly: the multicenter prospective cohort GARLIT study.
Vernieri F, Brunelli N, Marcosano M, Aurilia C, Egeo G, Lovati C, Favoni V, Perrotta A, Maestrini I, Rao R, d'Onofrio L, Finocchi C, Aguggia M, Bono F, Ranieri A, Albanese M, Di Piero V, Cevoli S, Altamura C, Barbanti P
